Back to search

Institutes outside Greece

Beyond the average treatment effect: risk-based approaches to medical decision making

Abstract

dc:description

Doctors typically align clinical treatments with average effects observed in clinical trials, assuming all patients respond similarly. However, these average effects often conceal substantial variability (heterogeneity) in patient responses, limiting their applicability for individual patient decisions. Baseline risk, or a patient's likelihood of experiencing a particular outcome, critically influences treatment effectiveness. Patients with higher baseline risk generally gain more substantial benefits from treatment compared to low-risk patients. Thus, baseline risk assessment through predictive modeling is essential for personalized medical decision-making. Healthcare data collected routinely from hospitals, insurers, and primary care providers presents significant potential for developing risk-based predictive models. Nevertheless, observational data analyses face challenges, notably confounding, because treatment assignment in routine care is non-random. Furthermore, inconsistencies in data formats complicate the integration of multiple data sources. Standardized data frameworks like the OMOP Common Data Model (OMOP-CDM) facilitate large-scale observational studies, mitigating these challenges. This thesis systematically reviews methodologies addressing treatment effect heterogeneity, categorizing them into risk-based methods, treatment effect modeling, and optimal treatment regimes. A structured, risk-based analytical framework is developed and applied across clinical trial data and observational datasets, including comparisons between antihypertensive therapies and osteoporosis treatments. Extensive simulations indicate that regression models incorporating linear interactions between baseline risk and treatment yield reliable personalized predictions even with modest sample sizes. Practical predictive models for melanoma recurrence and mortality, as well as COVID-19 outcomes, are also presented. Overall, the thesis highlights the importance of incorporating baseline risk into clinical decisions, advocating for risk-based approaches to better tailor treatments to individual patient profiles.

Degree

thesis:*
Grantor dc:publisher
Institutes outside Greece
Year dc:date
2023

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Rekkas, Alexandros
  • Ρέκκας, Αλέξανδρος

Subjects

dc:subject × 25

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/59485

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Rekkas, Alexandros; Ρέκκας, Αλέξανδρος. Beyond the average treatment effect: risk-based approaches to medical decision making. Institutes outside Greece, 2023. http://hdl.handle.net/10442/hedi/59485